Skip to main content
Year archive

HLB Life Science CO.,LTD. — 2025 filings

All 37 regulatory filings released by HLB Life Science CO.,LTD. (067630) in 2025, sourced directly from the official regulator.

37 Filings
2025 Period
2025 filings (37)
Filing Released Lang
대표이사변경
Board/Management Information
2025-12-31 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2025-12-16 Korean
주요사항보고서(교환사채권발행결정)
Capital/Financing Update
2025-11-03 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-13 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2025-08-01 Korean
기타주요경영사항 (회사 합병결정 철회)
M&A Activity
2025-08-01 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-07-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-06-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-06-19 Korean
전환가액의조정 (제13회차)
Capital/Financing Update
2025-05-29 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2025-05-19 Korean
[기재정정]주주총회소집결의
AGM Information
2025-05-19 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-15 Korean
기타시장안내 (에이치엘비생명과학 9WR 신주인수권 행사기간 만료 및 상장폐지 예고)
Delisting Announcement
2025-04-15 Korean
임원ㆍ주요주주특정증권등거래계획철회보고서
Director's Dealing
2025-04-10 Korean
전환가액의조정 (제14회차)
Share Issue/Capital Change
2025-04-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-04-08 Korean
전환가액의조정 (제11회차)
Capital/Financing Update
2025-04-07 Korean
주권매매거래정지 (합병)
Delisting Announcement
2025-04-01 Korean
주요사항보고서(회사합병결정)
M&A Activity
2025-04-01 Korean
주주총회소집결의
AGM Information
2025-04-01 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2025-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-28 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-20 Korean
사업보고서 (2024.12)
Audit Report / Information FY 2024
2025-03-20 Korean
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득
Capital/Financing Update
2025-03-17 Korean
주주총회소집결의
AGM Information
2025-03-04 Korean
주주총회집중일개최사유신고
AGM Information
2025-03-04 Korean
주주총회소집공고
AGM Information
2025-03-04 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-03-04 Korean
전환가액의조정
Capital/Financing Update
2025-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2024
2025-02-17 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing
2025-02-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-01-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-01-22 Korean
증권발행결과(자율공시)
Capital/Financing Update
2025-01-10 Korean
주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change
2025-01-08 Korean